Catalyst Wire Dossier Catalyst Wire Dossier

icotinib

icotinib
Drug timelines are a Plus or Pro feature.

67 regulatory and trial events tracked for icotinib, covering 2012-05-24 to 2026-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Bevacizumab Combined With Double Doses of Icotinib in Advanced NSCLC Patients With EGFR L858R Mutation [Phase 2]

See pricing